nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—DRD5—Signaling by GPCR—HRAS—ocular cancer	0.000463	0.000463	CbGpPWpGaD
Pergolide—ADRA2A—Hemostasis—TGFB1—ocular cancer	0.00046	0.00046	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—E2F1—ocular cancer	0.000456	0.000456	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—CDKN1B—ocular cancer	0.000455	0.000455	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CDKN2B—ocular cancer	0.000451	0.000451	CbGpPWpGaD
Pergolide—DRD5—GPCR downstream signaling—AKT1—ocular cancer	0.00045	0.00045	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—HDAC1—ocular cancer	0.00045	0.00045	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—E2F1—ocular cancer	0.000449	0.000449	CbGpPWpGaD
Pergolide—ADRA2C—Hemostasis—HRAS—ocular cancer	0.000446	0.000446	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CDKN2B—ocular cancer	0.000444	0.000444	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CDKN2B—ocular cancer	0.000434	0.000434	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—CCND1—ocular cancer	0.000434	0.000434	CbGpPWpGaD
Pergolide—ADRA2B—Hemostasis—AKT1—ocular cancer	0.000422	0.000422	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—CDKN1A—ocular cancer	0.00042	0.00042	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—GNA11—ocular cancer	0.000419	0.000419	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—E2F1—ocular cancer	0.000414	0.000414	CbGpPWpGaD
Pergolide—DRD5—Signaling by GPCR—AKT1—ocular cancer	0.000409	0.000409	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—E2F1—ocular cancer	0.000407	0.000407	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CDKN2B—ocular cancer	0.000404	0.000404	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—EP300—ocular cancer	0.0004	0.0004	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—E2F1—ocular cancer	0.000399	0.000399	CbGpPWpGaD
Pergolide—ADRA2C—Hemostasis—AKT1—ocular cancer	0.000394	0.000394	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—GNAQ—ocular cancer	0.000389	0.000389	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—MDM2—ocular cancer	0.000382	0.000382	CbGpPWpGaD
Pergolide—ADRA2A—Hemostasis—TP53—ocular cancer	0.000379	0.000379	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—MDM2—ocular cancer	0.000374	0.000374	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—E2F1—ocular cancer	0.00037	0.00037	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—MDM2—ocular cancer	0.000368	0.000368	CbGpPWpGaD
Pergolide—ADRA2A—Hemostasis—HRAS—ocular cancer	0.000362	0.000362	CbGpPWpGaD
Pergolide—HTR1D—Signaling by GPCR—HRAS—ocular cancer	0.000355	0.000355	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—MDM2—ocular cancer	0.000351	0.000351	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—CDKN1B—ocular cancer	0.000349	0.000349	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—MYC—ocular cancer	0.000348	0.000348	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—TGFB1—ocular cancer	0.000347	0.000347	CbGpPWpGaD
Pergolide—HTR1B—Signaling by GPCR—HRAS—ocular cancer	0.000347	0.000347	CbGpPWpGaD
Pergolide—HTR1D—GPCR downstream signaling—AKT1—ocular cancer	0.000345	0.000345	CbGpPWpGaD
Pergolide—DRD4—Signaling by GPCR—HRAS—ocular cancer	0.000342	0.000342	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—CDKN1B—ocular cancer	0.000341	0.000341	CbGpPWpGaD
Pergolide—HTR1B—GPCR downstream signaling—AKT1—ocular cancer	0.000338	0.000338	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—CDKN1B—ocular cancer	0.000336	0.000336	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—CCND1—ocular cancer	0.000333	0.000333	CbGpPWpGaD
Pergolide—DRD4—GPCR downstream signaling—AKT1—ocular cancer	0.000332	0.000332	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—MDM2—ocular cancer	0.000331	0.000331	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—MDM2—ocular cancer	0.000327	0.000327	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—MDM2—ocular cancer	0.000327	0.000327	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—HRAS—ocular cancer	0.000326	0.000326	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—CCND1—ocular cancer	0.000326	0.000326	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—CDKN1A—ocular cancer	0.000322	0.000322	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—CDKN1B—ocular cancer	0.000321	0.000321	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—CCND1—ocular cancer	0.00032	0.00032	CbGpPWpGaD
Pergolide—ADRA2A—Hemostasis—AKT1—ocular cancer	0.00032	0.00032	CbGpPWpGaD
Pergolide—HTR2B—GPCR downstream signaling—AKT1—ocular cancer	0.000317	0.000317	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—CDKN1A—ocular cancer	0.000315	0.000315	CbGpPWpGaD
Pergolide—HTR1D—Signaling by GPCR—AKT1—ocular cancer	0.000313	0.000313	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—CDKN1A—ocular cancer	0.00031	0.00031	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—HRAS—ocular cancer	0.000308	0.000308	CbGpPWpGaD
Pergolide—HTR1B—Signaling by GPCR—AKT1—ocular cancer	0.000307	0.000307	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—EP300—ocular cancer	0.000306	0.000306	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—CCND1—ocular cancer	0.000306	0.000306	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—HRAS—ocular cancer	0.000304	0.000304	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—HRAS—ocular cancer	0.000304	0.000304	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—CDKN1B—ocular cancer	0.000302	0.000302	CbGpPWpGaD
Pergolide—DRD4—Signaling by GPCR—AKT1—ocular cancer	0.000302	0.000302	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—EP300—ocular cancer	0.0003	0.0003	CbGpPWpGaD
Pergolide—DRD1—GPCR downstream signaling—AKT1—ocular cancer	0.000299	0.000299	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—CDKN1B—ocular cancer	0.000298	0.000298	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—CDKN1B—ocular cancer	0.000298	0.000298	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—CDKN1A—ocular cancer	0.000296	0.000296	CbGpPWpGaD
Pergolide—ADRA1D—GPCR downstream signaling—AKT1—ocular cancer	0.000295	0.000295	CbGpPWpGaD
Pergolide—DRD3—GPCR downstream signaling—AKT1—ocular cancer	0.000295	0.000295	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MDM2—ocular cancer	0.000295	0.000295	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—EP300—ocular cancer	0.000295	0.000295	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—CCND1—ocular cancer	0.000288	0.000288	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—AKT1—ocular cancer	0.000288	0.000288	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—TP53—ocular cancer	0.000286	0.000286	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MDM2—ocular cancer	0.000285	0.000285	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—CCND1—ocular cancer	0.000285	0.000285	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—CCND1—ocular cancer	0.000285	0.000285	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MDM2—ocular cancer	0.000283	0.000283	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—EP300—ocular cancer	0.000282	0.000282	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—CDKN1A—ocular cancer	0.000279	0.000279	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MDM2—ocular cancer	0.000276	0.000276	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—CDKN1A—ocular cancer	0.000275	0.000275	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—CDKN1A—ocular cancer	0.000275	0.000275	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—HRAS—ocular cancer	0.000274	0.000274	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GNA11—ocular cancer	0.000274	0.000274	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—HRAS—ocular cancer	0.000273	0.000273	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—AKT1—ocular cancer	0.000272	0.000272	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MDM2—ocular cancer	0.000271	0.000271	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CDKN1B—ocular cancer	0.000269	0.000269	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—AKT1—ocular cancer	0.000268	0.000268	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—AKT1—ocular cancer	0.000268	0.000268	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—MYC—ocular cancer	0.000267	0.000267	CbGpPWpGaD
Pergolide—ADRA2B—GPCR downstream signaling—AKT1—ocular cancer	0.000266	0.000266	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—TGFB1—ocular cancer	0.000266	0.000266	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—EP300—ocular cancer	0.000266	0.000266	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—HRAS—ocular cancer	0.000265	0.000265	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—EP300—ocular cancer	0.000264	0.000264	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—HRAS—ocular cancer	0.000263	0.000263	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—EP300—ocular cancer	0.000262	0.000262	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—EP300—ocular cancer	0.000262	0.000262	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—MYC—ocular cancer	0.000261	0.000261	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—TGFB1—ocular cancer	0.000261	0.000261	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CDKN1B—ocular cancer	0.00026	0.00026	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CDKN1B—ocular cancer	0.000259	0.000259	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—AKT1—ocular cancer	0.000257	0.000257	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—MYC—ocular cancer	0.000257	0.000257	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CCND1—ocular cancer	0.000257	0.000257	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—TGFB1—ocular cancer	0.000256	0.000256	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—HRAS—ocular cancer	0.000256	0.000256	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—AKT1—ocular cancer	0.000256	0.000256	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GNAQ—ocular cancer	0.000254	0.000254	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—HRAS—ocular cancer	0.000252	0.000252	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CDKN1B—ocular cancer	0.000252	0.000252	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MDM2—ocular cancer	0.00025	0.00025	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—AKT1—ocular cancer	0.000249	0.000249	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CDKN1A—ocular cancer	0.000249	0.000249	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CCND1—ocular cancer	0.000248	0.000248	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CDKN1B—ocular cancer	0.000248	0.000248	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CCND1—ocular cancer	0.000247	0.000247	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MDM2—ocular cancer	0.000246	0.000246	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—MYC—ocular cancer	0.000245	0.000245	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—AKT1—ocular cancer	0.000245	0.000245	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—TGFB1—ocular cancer	0.000245	0.000245	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—AKT1—ocular cancer	0.000242	0.000242	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—AKT1—ocular cancer	0.000241	0.000241	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MDM2—ocular cancer	0.000241	0.000241	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CCND1—ocular cancer	0.00024	0.00024	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CDKN1A—ocular cancer	0.00024	0.00024	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CDKN1A—ocular cancer	0.000239	0.000239	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—EP300—ocular cancer	0.000237	0.000237	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CCND1—ocular cancer	0.000236	0.000236	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—AKT1—ocular cancer	0.000234	0.000234	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—AKT1—ocular cancer	0.000232	0.000232	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—HRAS—ocular cancer	0.000232	0.000232	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CDKN1A—ocular cancer	0.000232	0.000232	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—MYC—ocular cancer	0.000231	0.000231	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—TGFB1—ocular cancer	0.000231	0.000231	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—HRAS—ocular cancer	0.000229	0.000229	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CDKN1A—ocular cancer	0.000229	0.000229	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—EP300—ocular cancer	0.000228	0.000228	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CDKN1B—ocular cancer	0.000228	0.000228	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—MYC—ocular cancer	0.000228	0.000228	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—MYC—ocular cancer	0.000228	0.000228	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—TGFB1—ocular cancer	0.000228	0.000228	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—TGFB1—ocular cancer	0.000228	0.000228	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—EP300—ocular cancer	0.000227	0.000227	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—AKT1—ocular cancer	0.000226	0.000226	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—AKT1—ocular cancer	0.000226	0.000226	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CDKN1B—ocular cancer	0.000225	0.000225	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MDM2—ocular cancer	0.000224	0.000224	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—HRAS—ocular cancer	0.000224	0.000224	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—AKT1—ocular cancer	0.000222	0.000222	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—AKT1—ocular cancer	0.000222	0.000222	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—EP300—ocular cancer	0.000221	0.000221	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CDKN1B—ocular cancer	0.00022	0.00022	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—TP53—ocular cancer	0.000219	0.000219	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CCND1—ocular cancer	0.000218	0.000218	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—AKT1—ocular cancer	0.000218	0.000218	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—EP300—ocular cancer	0.000217	0.000217	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—EP300—ocular cancer	0.000215	0.000215	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—TP53—ocular cancer	0.000214	0.000214	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CCND1—ocular cancer	0.000214	0.000214	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—TP53—ocular cancer	0.000211	0.000211	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CDKN1A—ocular cancer	0.000211	0.000211	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CCND1—ocular cancer	0.00021	0.00021	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—HRAS—ocular cancer	0.000209	0.000209	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—HRAS—ocular cancer	0.000208	0.000208	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CDKN1A—ocular cancer	0.000207	0.000207	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MYC—ocular cancer	0.000206	0.000206	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TGFB1—ocular cancer	0.000206	0.000206	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—HRAS—ocular cancer	0.000205	0.000205	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—AKT1—ocular cancer	0.000205	0.000205	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CDKN1B—ocular cancer	0.000204	0.000204	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CDKN1A—ocular cancer	0.000203	0.000203	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—AKT1—ocular cancer	0.000202	0.000202	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—HRAS—ocular cancer	0.000202	0.000202	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—AKT1—ocular cancer	0.000202	0.000202	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—TP53—ocular cancer	0.000201	0.000201	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—EP300—ocular cancer	0.0002	0.0002	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MYC—ocular cancer	0.000199	0.000199	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TGFB1—ocular cancer	0.000198	0.000198	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MYC—ocular cancer	0.000198	0.000198	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—AKT1—ocular cancer	0.000198	0.000198	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TGFB1—ocular cancer	0.000197	0.000197	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—EP300—ocular cancer	0.000197	0.000197	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CCND1—ocular cancer	0.000195	0.000195	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—EP300—ocular cancer	0.000193	0.000193	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—HRAS—ocular cancer	0.000193	0.000193	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MYC—ocular cancer	0.000193	0.000193	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TGFB1—ocular cancer	0.000192	0.000192	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—TP53—ocular cancer	0.00019	0.00019	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MYC—ocular cancer	0.000189	0.000189	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TGFB1—ocular cancer	0.000189	0.000189	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CDKN1A—ocular cancer	0.000189	0.000189	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—TP53—ocular cancer	0.000187	0.000187	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—TP53—ocular cancer	0.000187	0.000187	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—AKT1—ocular cancer	0.000185	0.000185	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—AKT1—ocular cancer	0.000184	0.000184	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—HRAS—ocular cancer	0.000182	0.000182	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—AKT1—ocular cancer	0.000181	0.000181	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—EP300—ocular cancer	0.000179	0.000179	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—HRAS—ocular cancer	0.000179	0.000179	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—HRAS—ocular cancer	0.000179	0.000179	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—AKT1—ocular cancer	0.000178	0.000178	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MYC—ocular cancer	0.000175	0.000175	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TGFB1—ocular cancer	0.000174	0.000174	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MYC—ocular cancer	0.000172	0.000172	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TGFB1—ocular cancer	0.000171	0.000171	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—AKT1—ocular cancer	0.00017	0.00017	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TP53—ocular cancer	0.000169	0.000169	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MYC—ocular cancer	0.000168	0.000168	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TGFB1—ocular cancer	0.000168	0.000168	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TP53—ocular cancer	0.000163	0.000163	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TP53—ocular cancer	0.000163	0.000163	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—HRAS—ocular cancer	0.000162	0.000162	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—AKT1—ocular cancer	0.00016	0.00016	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—AKT1—ocular cancer	0.00016	0.00016	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—AKT1—ocular cancer	0.000158	0.000158	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—AKT1—ocular cancer	0.000158	0.000158	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TP53—ocular cancer	0.000158	0.000158	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MYC—ocular cancer	0.000156	0.000156	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—HRAS—ocular cancer	0.000156	0.000156	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TGFB1—ocular cancer	0.000156	0.000156	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TP53—ocular cancer	0.000156	0.000156	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—HRAS—ocular cancer	0.000155	0.000155	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—HRAS—ocular cancer	0.000151	0.000151	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—HRAS—ocular cancer	0.000149	0.000149	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TP53—ocular cancer	0.000143	0.000143	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—AKT1—ocular cancer	0.000143	0.000143	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TP53—ocular cancer	0.000141	0.000141	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—EP300—ocular cancer	0.00014	0.00014	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TP53—ocular cancer	0.000138	0.000138	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—AKT1—ocular cancer	0.000138	0.000138	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—AKT1—ocular cancer	0.000137	0.000137	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—HRAS—ocular cancer	0.000137	0.000137	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—HRAS—ocular cancer	0.000135	0.000135	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—AKT1—ocular cancer	0.000134	0.000134	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—HRAS—ocular cancer	0.000132	0.000132	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—AKT1—ocular cancer	0.000131	0.000131	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—AKT1—ocular cancer	0.00013	0.00013	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TP53—ocular cancer	0.000128	0.000128	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—HRAS—ocular cancer	0.000123	0.000123	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—AKT1—ocular cancer	0.000121	0.000121	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—AKT1—ocular cancer	0.000119	0.000119	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—AKT1—ocular cancer	0.000117	0.000117	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—AKT1—ocular cancer	0.000108	0.000108	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—EP300—ocular cancer	9.14e-05	9.14e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—AKT1—ocular cancer	8.45e-05	8.45e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—AKT1—ocular cancer	5.53e-05	5.53e-05	CbGpPWpGaD
